Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Elevance Health (NYSE:ELV) Stock Price
Elevance Health (NYSE:ELV – Get Free Report) had its price target increased by analysts at Deutsche Bank Aktiengesellschaft from $332.00 to $363.00 in a report issued on Thursday,MarketScreener reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of 5.03% from the stock’s previous close. […]
24 Apr 10:50 · The Cerbat Gem